An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcaemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

Trial Profile

An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcaemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Mar 2017

At a glance

  • Drugs Cinacalcet (Primary)
  • Indications Hypercalcaemia; Primary hyperparathyroidism
  • Focus Registrational; Therapeutic Use
  • Sponsors Kyowa Hakko Kirin
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 10 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top